Biocon is committed to address the world’s developmental challenges
Biocon is committed to address the world’s developmental challenges
Behind consistent growth is good governance.
Insulin Glargine: Journey to the historic U.S. approval for the first interchangeable biosimilar
Biocon Statement on Parts of the Charge Sheet Leaked to a Media Outlet
Biocon Biologics Consolidated Statement on USFDA Inspections
Kiran Mazumdar-Shaw Awarded with H.K. Firodia Lifetime Achievement Award 2022 for Excellence in Science & Technology
Kiran Mazumdar-Shaw speaking on Biocon’s Q1 FY23 Earnings
#SheInspires, The inspiring tales of our own Women In Science at Biocon Biologics.
NOVEL BIOLOGICS
We are a global biopharmaceutical company with the belief that everyone, everywhere deserves access to affordable quality medicines.
We are a global biopharmaceutical company with the belief that everyone, everywhere deserves access to affordable quality medicines.
Previous
Next
Close
Test Caption
Test Description goes like this